Large-scale production facility completed for GBP410, a 21-valent pneumococcal conjugate vaccine can...

No patent infringement found in exports of individual conjugate bulk substances and research-use fin...

Company strengthens global presence through participation in major international bio events.Company ...

Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness.SK ...

Commissioner Youngmee Jee of the Korea Disease Control and Prevention Agency and Director General Je...

SK bioscience wins case two years after filing suit challenging global company´s patent monopo...

-Award established in 2021 to honor the legacy of the late Vice Chairman Park MahnHoon and promote v...

750,000 doses of influenza vaccine to be supplied to Southeast Asia and Latin America in the first h...

SKYVaricella®, supplied to Latin America since 2022 through PAHO, secures an additional three-year s...

SK bioscience’s first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Z...

? SK-Sanofi launches RSV preventive antibody injection for all infants under 12 months.? RSV, a majo...

-Collaborated with key global health authorities, including IVI, the U.S. FDA, and the U.K. MHRA-The...